Suraj G. Bhansali

1.1k total citations
20 papers, 817 citations indexed

About

Suraj G. Bhansali is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Suraj G. Bhansali has authored 20 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Suraj G. Bhansali's work include Advanced Breast Cancer Therapies (8 papers), Cancer Treatment and Pharmacology (3 papers) and Lymphatic System and Diseases (2 papers). Suraj G. Bhansali is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Cancer Treatment and Pharmacology (3 papers) and Lymphatic System and Diseases (2 papers). Suraj G. Bhansali collaborates with scholars based in United States, Switzerland and France. Suraj G. Bhansali's co-authors include Marilyn E. Morris, W. Richter, Alessandro Matano, Sudha Parasuraman, Manisha Sonee, Suman Mukherjee, Muaiad Kittaneh, Michael A. Postow, Jeffrey A. Sosman and Fang Wu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Suraj G. Bhansali

20 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suraj G. Bhansali United States	13	381	263	189	167	126	20	817
Zhilei Lv China	13	303 0.8×	300 1.1×	208 1.1×	209 1.3×	66 0.5×	25	935
Moo Jun Baek South Korea	20	532 1.4×	492 1.9×	196 1.0×	174 1.0×	62 0.5×	87	1.3k
Peng Yuan China	21	380 1.0×	409 1.6×	154 0.8×	35 0.2×	263 2.1×	69	1.2k
Volker Huck Germany	19	240 0.6×	100 0.4×	189 1.0×	264 1.6×	50 0.4×	42	1.1k
Jinshuo Fan China	15	490 1.3×	280 1.1×	217 1.1×	258 1.5×	62 0.5×	27	1.1k
Julianne D. Twomey United States	10	302 0.8×	504 1.9×	101 0.5×	256 1.5×	134 1.1×	18	988
Khashayar Esfahani Canada	11	374 1.0×	741 2.8×	203 1.1×	430 2.6×	64 0.5×	37	1.3k
DJ Kerr United Kingdom	20	223 0.6×	598 2.3×	188 1.0×	98 0.6×	72 0.6×	53	1.2k
Julia Paik New Zealand	14	234 0.6×	189 0.7×	73 0.4×	120 0.7×	24 0.2×	28	765
Weiye Deng United States	19	419 1.1×	623 2.4×	381 2.0×	377 2.3×	136 1.1×	43	1.5k

Countries citing papers authored by Suraj G. Bhansali

Since Specialization

Citations

This map shows the geographic impact of Suraj G. Bhansali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suraj G. Bhansali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suraj G. Bhansali more than expected).

Fields of papers citing papers by Suraj G. Bhansali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suraj G. Bhansali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suraj G. Bhansali. The network helps show where Suraj G. Bhansali may publish in the future.

Co-authorship network of co-authors of Suraj G. Bhansali

This figure shows the co-authorship network connecting the top 25 collaborators of Suraj G. Bhansali. A scholar is included among the top collaborators of Suraj G. Bhansali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suraj G. Bhansali. Suraj G. Bhansali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhansali, Suraj G., et al.. (2024). Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis. The Journal of Clinical Pharmacology. 64(12). 1528–1540. 1 indexed citations

Juric, Dejan, Giuseppe Curigliano, Sara Cresta, et al.. (2018). Abstract P5-21-04: Phase I/Ib study of the SERD LSZ102 alone or in combination with ribociclib in ER+ breast cancer. Cancer Research. 78(4_Supplement). P5–21. 8 indexed citations

Geoerger, Birgit, Franck Bourdeaut, Steven G. DuBois, et al.. (2017). A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors. Clinical Cancer Research. 23(10). 2433–2441. 121 indexed citations

Gattorno, Marco, Laura Obici, Marco Cattalini, et al.. (2016). Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Annals of the Rheumatic Diseases. 76(1). 173–178. 66 indexed citations

Chen, Jin, Suraj G. Bhansali, Tapan Majumdar, et al.. (2015). Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(4). 317–24. 1 indexed citations

Juric, Dejan, Erika Hamilton, Laura García‐Estévez, et al.. (2015). Abstract P5-19-24: Phase Ib/II study of LEE011 and BYL719 and letrozole in ER+, HER2– breast cancer: Safety, preliminary efficacy and molecular analysis. Cancer Research. 75(9_Supplement). P5–19. 15 indexed citations

Herpen, C. van, Michael A. Postow, Matteo S. Carlino, et al.. (2015). 3300 A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma. European Journal of Cancer. 51. S663–S663. 18 indexed citations

Sosman, Jeffrey A., Muaiad Kittaneh, Martijn P. Lolkema, et al.. (2014). A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity.. Journal of Clinical Oncology. 32(15_suppl). 9009–9009. 88 indexed citations

Bhansali, Suraj G., Kathleen M. Mullane, Lillian Ting, et al.. (2014). Pharmacokinetics of LFF571 and Vancomycin in Patients with Moderate Clostridium difficile Infections. Antimicrobial Agents and Chemotherapy. 59(3). 1441–1445. 30 indexed citations

10.

Münster, Pamela N., Erika Hamilton, Laura García‐Estévez, et al.. (2014). Ph IB study of LEE011 and BYL719 in combination with letrozole in ER+, HER2- breast cancer.. Journal of Clinical Oncology. 32(26_suppl). 143–143. 21 indexed citations

11.

Bardia, Aditya, Shanu Modi, Mario Campone, et al.. (2014). 500 Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2− advanced/metastatic breast cancer: results from a Phase Ib clinical trial. European Journal of Cancer. 50. 163–163. 4 indexed citations

12.

Münster, Pamela N., et al.. (2014). Phase lb study of LEE011 and BYL719 in combination with letrozole in estrogen receptor-positive, HER2-negative breast cancer (ER+, HER2− BC).. Journal of Clinical Oncology. 32(15_suppl). 533–533. 28 indexed citations

13.

Bardia, Aditya, Shanu Modi, Muaiad Kittaneh, et al.. (2014). Phase Ib/II study of LEE011, everolimus, and exemestane in postmenopausal women with ER+/HER2-metastatic breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 535–535. 19 indexed citations

14.

Wu, Fang, Suraj G. Bhansali, Wing‐Cheung Law, et al.. (2012). Fluorescence Imaging of the Lymph Node Uptake of Proteins in Mice after Subcutaneous Injection: Molecular Weight Dependence. Pharmaceutical Research. 29(7). 1843–1853. 48 indexed citations

15.

Wu, Fang, Suraj G. Bhansali, Rajiv Kumar, et al.. (2012). Noninvasive Real-Time Fluorescence Imaging of the Lymphatic uptake of BSA–IRDye 680 Conjugate Administered Subcutaneously in Mice. Journal of Pharmaceutical Sciences. 101(5). 1744–1754. 11 indexed citations

16.

Richter, W., Suraj G. Bhansali, & Marilyn E. Morris. (2012). Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration. The AAPS Journal. 14(3). 559–570. 266 indexed citations

17.

Bhansali, Suraj G., Sathy V. Balu‐Iyer, & Marilyn E. Morris. (2011). Influence of Route of Administration and Liposomal Encapsulation on Blood and Lymph Node Exposure to the Protein VEGF-C156S. Journal of Pharmaceutical Sciences. 101(2). 852–859. 7 indexed citations

18.

Morris, Marilyn E., Xinning Yang, Yash Gandhi, Suraj G. Bhansali, & Lisa J. Benincosa. (2011). Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR. Biopharmaceutics & Drug Disposition. 33(1). 1–14. 7 indexed citations

19.

Bhansali, Suraj G., Daniel A. Brazeau, Manisha Sonee, & Suman Mukherjee. (2006). Nicotinamide Prevents Apoptosis in Human Cortical Neuronal Cells. Toxicology Mechanisms and Methods. 16(4). 173–180. 13 indexed citations

20.

Bhansali, Suraj G., et al.. (2004). A comparative study of the effect of oxidative stress on the cytoskeleton in human cortical neurons. Toxicology and Applied Pharmacology. 196(1). 29–36. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact